The safety of the temozolomide in patients with malignant glioma
A Dario, G Tomei - Current drug safety, 2006 - ingentaconnect.com
The temozolomide is a promising orally cytotoxic agent used in malignant glioma. The
survival curve improvement after drug administration appears to be statistically significant …
survival curve improvement after drug administration appears to be statistically significant …
[引用][C] The Safety of the Temozolomide in Patients with Malignant Glioma
A Dario, G Tomei - Current Drug Safety, 2006 - cir.nii.ac.jp
The Safety of the Temozolomide in Patients with Malignant Glioma | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
The safety of the temozolomide in patients with malignant glioma
A Dario, G Tomei - Current drug safety, 2006 - pubmed.ncbi.nlm.nih.gov
The temozolomide is a promising orally cytotoxic agent used in malignant glioma. The
survival curve improvement after drug administration appears to be statistically significant …
survival curve improvement after drug administration appears to be statistically significant …
The safety of the temozolomide in patients with malignant glioma.
A Dario, G Tomei - Current Drug Safety, 2006 - europepmc.org
The temozolomide is a promising orally cytotoxic agent used in malignant glioma. The
survival curve improvement after drug administration appears to be statistically significant …
survival curve improvement after drug administration appears to be statistically significant …